secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2025-08-29T23:59:59+00:00
Accession:  0000950170-25-112267
Event type: leadership
Sentiment:  neutral
Materiality: 0.70
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia CFO Mark Kawakami resigns; CEO Schaefer adds interim CFO role
---------------------------------------------------------------------

- CFO Mark Kawakami resigns effective September 12, 2025; not due to any disagreement with the Company or auditors.
- CEO Thomas J. Schaefer appointed interim CFO and principal accounting officer, effective upon Kawakami's resignation.
- Schaefer previously served as CFO from January 2023 to July 2024; no compensation change for the additional role.
- Schaefer will be available as an advisor after his departure; transition proceeds smoothly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000095017025112267/0000950170-25-112267-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000095017025112267/rkda-20250826.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-112267

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer